Nifty

:

14310.80

Sensex

:

47883.38

-524.05 (-3.53%)
-1707.94 (-3.44%)

Login

Nifty
Sensex

:
:

14310.80
47883.38

-524.05 (-3.53%)
-1707.94 (-3.44%)

Vivimed Labs Ltd.

Pharmaceuticals & Drugs

Rating :

38/99

BSE: 532660 | NSE: VIVIMEDLAB

Watchlist

NSE BSE

16.20

12-Apr-2021

Open
High
Low
Previous Close

17.10
17.10
15.85
17.15

Volume
Traded Value (lacs)
52 Week High
52 Week Low

262907
43.00
23.35
9.80

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

134.32
N/A
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,026.52
N/A
0.18

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.79
-4.68
-3.70

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-22.74
-50.60
-49.55

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

4.47
3.45
2.24

P:BV (Average)

8 Years
5 Years
3 Years

0.77
0.64
0.25

EV:EBITDA (Average)

8 Years
5 Years
3 Years

8.71
10.46
13.63

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 62.44 62.77 -0.53% 59.40 99.62 -40.37% 53.53 59.11 -9.44% 55.10 74.60 -26.14%
Expenses 48.72 52.59 -7.36% 46.42 90.14 -48.50% 38.15 46.48 -17.92% 55.11 57.31 -3.84%
EBITDA 13.71 10.18 34.68% 12.98 9.49 36.78% 15.38 12.63 21.77% -0.01 17.29 -
EBIDTM 21.97% 16.22% 21.85% 9.52% 28.74% 21.37% -0.02% 23.17%
Other Income 1.57 1.31 19.85% 1.36 1.01 34.65% 1.36 2.63 -48.29% 1.59 7.64 -79.19%
Interest 11.13 11.85 -6.08% 9.83 11.15 -11.84% 11.40 9.97 14.34% 10.02 18.14 -44.76%
Depreciation 3.95 4.17 -5.28% 3.95 4.19 -5.73% 3.94 4.29 -8.16% 3.92 4.70 -16.60%
PBT 0.21 -4.53 - 0.55 -4.85 - 1.40 1.00 40.00% -12.35 2.09 -
Tax 0.00 0.00 0 0.00 -1.21 - 0.23 0.25 -8.00% -0.61 -0.42 -
PAT 0.21 -4.53 - 0.55 -3.64 - 1.17 0.75 56.00% -11.74 2.51 -
PATM 0.33% -7.22% 0.93% -3.65% 2.19% 1.27% -21.31% 3.37%
EPS 0.02 -0.55 - 0.07 -0.44 - 0.14 0.09 55.56% -1.42 0.30 -

Description Dec 20 Dec 19 Var% Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var%
Net Sales 277.94 197.70 40.59% 221.74 281.07 -21.11% 322.79 344.21 -6.22% 235.82 348.08 -32.25%
Expenses 299.80 206.57 45.13% 206.34 284.53 -27.48% 276.21 303.11 -8.87% 256.48 326.69 -21.49%
EBITDA -21.86 -8.87 - 15.41 -3.46 - 46.58 41.10 13.33% -20.66 21.39 -
EBIDTM -7.87% -4.49% 6.95% -1.23% 14.43% 11.94% -8.76% 6.14%
Other Income 4.34 2.09 107.66% 1.89 2.48 -23.79% 1.81 1.27 42.52% 2.42 6.10 -60.33%
Interest 16.13 16.48 -2.12% 13.65 15.59 -12.44% 14.88 12.11 22.87% 14.71 12.83 14.65%
Depreciation 16.52 15.62 5.76% 17.56 16.90 3.91% 17.29 16.95 2.01% 17.48 16.05 8.91%
PBT -50.17 -38.88 - -13.91 -33.47 - 16.22 13.31 21.86% -50.44 -1.40 -
Tax -0.62 -6.80 - -0.29 -7.12 - 3.38 3.16 6.96% 10.40 -1.41 -
PAT -49.55 -32.07 - -13.62 -26.35 - 12.84 10.15 26.50% -60.84 0.02 -
PATM -17.83% -16.22% -6.14% -9.38% 3.98% 2.95% -25.80% 0.00%
EPS -5.98 -3.87 - -1.64 -3.18 - 1.55 1.22 27.05% -7.34 0.00 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 230.47 276.61 251.81 261.39 569.84 319.39 430.15 431.99 423.13 382.90 309.81 Net Sales Growth -22.16% 9.85% -3.67% -54.13% 78.42% -25.75% -0.43% 2.09% 10.51% 23.59% Cost Of Goods Sold 110.71 150.30 80.30 86.40 179.93 131.55 197.90 234.65 239.81 227.73 194.39 Gross Profit 119.76 126.31 171.51 174.99 389.91 187.85 232.24 197.35 183.31 155.17 115.42 GP Margin 51.96% 45.66% 68.11% 66.95% 68.42% 58.82% 53.99% 45.68% 43.32% 40.52% 37.26% Total Expenditure 188.40 243.87 184.32 183.05 319.35 232.56 320.10 337.82 331.28 301.65 253.03 Power & Fuel Cost - 8.99 8.92 10.83 15.13 11.03 15.81 20.36 19.82 14.78 10.50 % Of Sales - 3.25% 3.54% 4.14% 2.66% 3.45% 3.68% 4.71% 4.68% 3.86% 3.39% Employee Cost - 31.87 37.88 34.09 42.23 23.99 27.88 19.83 15.51 10.58 10.54 % Of Sales - 11.52% 15.04% 13.04% 7.41% 7.51% 6.48% 4.59% 3.67% 2.76% 3.40% Manufacturing Exp. - 16.80 22.13 21.49 30.76 26.81 35.44 35.36 36.28 33.26 23.70 % Of Sales - 6.07% 8.79% 8.22% 5.40% 8.39% 8.24% 8.19% 8.57% 8.69% 7.65% General & Admin Exp. - 25.15 30.80 19.75 39.85 35.91 32.50 24.37 18.28 9.87 8.10 % Of Sales - 9.09% 12.23% 7.56% 6.99% 11.24% 7.56% 5.64% 4.32% 2.58% 2.61% Selling & Distn. Exp. - 3.03 4.28 5.28 3.21 3.27 3.61 3.25 1.57 5.42 4.37 % Of Sales - 1.10% 1.70% 2.02% 0.56% 1.02% 0.84% 0.75% 0.37% 1.42% 1.41% Miscellaneous Exp. - 7.75 0.01 5.21 8.23 0.00 6.94 0.00 0.00 0.00 4.37 % Of Sales - 2.80% 0.00% 1.99% 1.44% 0% 1.61% 0% 0% 0% 0.46% EBITDA 42.06 32.74 67.49 78.34 250.49 86.83 110.05 94.17 91.85 81.25 56.78 EBITDA Margin 18.25% 11.84% 26.80% 29.97% 43.96% 27.19% 25.58% 21.80% 21.71% 21.22% 18.33% Other Income 5.88 6.53 8.54 1.93 8.75 2.79 1.43 11.44 8.38 4.72 0.68 Interest 42.38 43.44 52.63 53.27 59.02 59.49 66.67 48.75 31.64 24.08 18.41 Depreciation 15.76 16.57 18.26 18.14 26.83 18.79 20.56 18.06 17.21 10.55 6.08 PBT -10.19 -20.74 5.13 8.85 173.39 11.34 24.25 38.81 51.38 51.34 32.97 Tax -0.38 -1.57 -1.05 -1.01 47.04 3.21 5.32 12.18 14.65 10.93 5.21 Tax Rate 3.73% 7.57% -20.47% -11.41% 27.13% 28.31% 21.94% 31.38% 28.51% 21.29% 15.80% PAT -9.81 -19.17 6.19 9.87 126.34 8.13 18.93 26.63 36.73 40.41 27.76 PAT before Minority Interest -9.81 -19.17 6.19 9.87 126.34 8.13 18.93 26.63 36.73 40.41 27.76 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -4.26% -6.93% 2.46% 3.78% 22.17% 2.55% 4.40% 6.16% 8.68% 10.55% 8.96% PAT Growth 0.00% - -37.28% -92.19% 1,454.00% -57.05% -28.91% -27.50% -9.11% 45.57% EPS -1.18 -2.31 0.75 1.19 15.24 0.98 2.28 3.21 4.43 4.87 3.35

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,058.29 1,058.80 1,315.17 1,185.66 1,461.91 1,345.63 1,380.10 1,350.83 1,108.80 668.31 416.00 Net Sales Growth -9.63% -19.49% 10.92% -18.90% 8.64% -2.50% 2.17% 21.83% 65.91% 60.65% Cost Of Goods Sold 420.91 462.55 518.40 479.67 536.28 624.05 646.23 656.33 513.27 337.39 236.97 Gross Profit 637.38 596.24 796.77 705.99 925.63 721.58 733.88 694.51 595.52 330.93 179.03 GP Margin 60.23% 56.31% 60.58% 59.54% 63.32% 53.62% 53.18% 51.41% 53.71% 49.52% 43.04% Total Expenditure 1,038.83 1,052.24 1,146.24 984.93 1,057.46 1,122.68 1,158.21 1,166.29 928.00 538.02 329.44 Power & Fuel Cost - 42.46 42.77 34.73 34.78 38.26 46.70 51.39 44.06 22.33 11.08 % Of Sales - 4.01% 3.25% 2.93% 2.38% 2.84% 3.38% 3.80% 3.97% 3.34% 2.66% Employee Cost - 233.36 241.76 197.78 189.98 176.94 184.43 162.66 50.33 32.19 19.97 % Of Sales - 22.04% 18.38% 16.68% 13.00% 13.15% 13.36% 12.04% 4.54% 4.82% 4.80% Manufacturing Exp. - 196.36 217.39 176.69 175.06 167.31 179.26 182.37 230.50 91.61 32.06 % Of Sales - 18.55% 16.53% 14.90% 11.97% 12.43% 12.99% 13.50% 20.79% 13.71% 7.71% General & Admin Exp. - 96.13 111.52 78.75 93.93 95.26 76.30 86.64 69.34 31.42 15.96 % Of Sales - 9.08% 8.48% 6.64% 6.43% 7.08% 5.53% 6.41% 6.25% 4.70% 3.84% Selling & Distn. Exp. - 13.82 14.41 16.66 15.39 20.86 25.29 26.91 20.50 23.09 11.26 % Of Sales - 1.31% 1.10% 1.41% 1.05% 1.55% 1.83% 1.99% 1.85% 3.45% 2.71% Miscellaneous Exp. - 7.56 0.00 0.65 12.03 0.00 0.00 0.00 0.00 0.00 11.26 % Of Sales - 0.71% 0% 0.05% 0.82% 0% 0% 0% 0% 0% 0.51% EBITDA 19.47 6.56 168.93 200.73 404.45 222.95 221.89 184.54 180.80 130.29 86.56 EBITDA Margin 1.84% 0.62% 12.84% 16.93% 27.67% 16.57% 16.08% 13.66% 16.31% 19.50% 20.81% Other Income 10.46 11.95 33.97 23.76 8.09 23.63 8.02 35.90 26.33 2.68 1.00 Interest 59.37 61.03 70.06 82.35 67.79 85.26 86.20 67.46 50.44 28.37 22.10 Depreciation 68.85 66.95 66.79 56.42 58.28 61.39 66.18 66.12 58.81 26.79 10.20 PBT -98.30 -109.47 66.05 85.71 286.48 99.93 77.54 86.86 97.88 77.82 55.26 Tax 12.87 -0.36 8.68 9.62 72.50 16.26 5.49 20.47 14.29 14.68 6.43 Tax Rate -13.09% 0.33% 13.14% 11.22% 25.31% 16.27% 7.08% 23.57% 14.60% 18.86% 11.64% PAT -111.17 -109.11 57.37 77.94 213.97 83.67 72.05 66.39 83.58 63.14 48.83 PAT before Minority Interest -111.17 -109.11 57.37 76.09 213.97 83.67 72.05 66.39 83.58 63.14 48.83 Minority Interest 0.00 0.00 0.00 1.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -10.50% -10.31% 4.36% 6.57% 14.64% 6.22% 5.22% 4.91% 7.54% 9.45% 11.74% PAT Growth 0.00% - -26.39% -63.57% 155.73% 16.13% 8.53% -20.57% 32.37% 29.31% EPS -13.41 -13.16 6.92 9.40 25.81 10.09 8.69 8.01 10.08 7.62 5.89

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 553.89 572.62 567.41 560.86 369.64 373.95 374.80 346.45 345.32 153.91 Share Capital 16.58 16.50 16.50 16.20 16.20 16.20 16.20 16.06 80.93 10.16 Total Reserves 537.31 556.12 550.90 544.66 353.44 357.75 356.22 328.01 262.01 134.89 Non-Current Liabilities 211.92 243.41 288.29 296.51 549.99 465.19 422.52 281.24 162.89 101.99 Secured Loans 12.29 34.39 66.66 131.24 143.28 260.86 250.36 142.21 75.71 74.74 Unsecured Loans 55.32 55.32 49.30 57.07 49.75 46.94 40.92 41.73 53.35 0.00 Long Term Provisions 3.84 9.54 7.17 2.74 3.38 3.01 2.35 1.97 1.81 1.65 Current Liabilities 301.51 338.52 399.72 503.14 445.75 463.61 406.10 327.11 269.28 172.60 Trade Payables 30.82 35.28 23.39 45.32 24.45 45.61 39.26 46.83 27.72 6.93 Other Current Liabilities 62.54 54.01 76.77 92.03 114.08 101.66 75.08 42.67 27.16 2.93 Short Term Borrowings 187.74 214.13 258.70 305.71 291.91 291.19 276.34 225.63 202.55 152.52 Short Term Provisions 20.41 35.10 40.86 60.07 15.31 25.15 15.42 11.97 11.84 10.22 Total Liabilities 1,067.32 1,154.55 1,255.42 1,360.51 1,365.38 1,302.75 1,203.42 954.80 777.49 428.50 Net Block 356.42 380.70 404.83 432.93 386.94 376.55 397.33 405.08 294.50 160.02 Gross Block 460.09 474.78 480.65 503.31 495.61 466.20 464.92 454.66 327.48 185.53 Accumulated Depreciation 103.67 94.08 75.82 70.39 108.67 89.65 67.59 49.58 32.98 25.50 Non Current Assets 513.68 532.41 599.47 579.17 657.81 669.87 640.39 509.84 389.37 164.56 Capital Work in Progress 69.77 64.18 42.78 58.64 40.83 63.27 15.51 9.21 7.71 1.14 Non Current Investment 87.50 87.53 151.87 87.60 230.05 230.05 227.55 95.55 87.17 3.40 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 553.63 622.14 655.94 781.34 707.57 632.89 563.03 444.90 358.05 257.26 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 263.37 282.45 292.54 285.66 268.17 222.50 170.13 140.36 73.88 66.70 Sundry Debtors 89.67 101.89 167.67 224.85 230.86 228.07 183.79 160.06 98.72 95.96 Cash & Bank 11.09 24.96 9.18 15.55 7.18 13.99 13.26 13.67 19.41 8.63 Other Current Assets 189.51 20.56 20.28 16.92 201.37 168.32 195.84 130.81 166.05 85.97 Short Term Loans & Adv. 168.91 192.30 166.27 238.34 175.74 162.39 189.91 124.88 165.82 85.39 Net Current Assets 252.13 283.62 256.22 278.20 261.82 169.27 156.93 117.79 88.77 84.66 Total Assets 1,067.31 1,154.55 1,255.41 1,360.51 1,365.38 1,302.76 1,203.42 954.80 777.48 428.51

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 834.59 943.79 1,226.40 734.21 585.15 559.24 560.36 509.14 474.79 196.71 Share Capital 341.80 341.73 341.73 16.20 80.15 80.15 80.15 80.01 144.88 10.16 Total Reserves 492.79 602.07 884.67 718.01 505.00 479.09 477.84 426.77 327.54 177.68 Non-Current Liabilities 590.94 489.65 356.86 503.86 561.11 538.36 532.58 449.68 360.72 148.25 Secured Loans 414.68 369.08 275.90 396.25 206.75 436.44 378.81 255.19 258.03 131.90 Unsecured Loans 55.71 55.72 49.30 57.07 50.52 46.94 40.92 41.73 53.35 0.00 Long Term Provisions 5.14 9.21 7.03 2.19 3.57 3.17 5.16 1.47 1.06 1.69 Current Liabilities 770.36 888.93 790.23 817.39 897.41 800.86 744.42 610.73 463.69 242.44 Trade Payables 226.50 294.42 201.99 178.59 166.74 188.71 190.49 166.28 156.86 44.06 Other Current Liabilities 101.78 227.11 147.64 179.92 285.85 176.38 138.78 116.10 40.79 4.68 Short Term Borrowings 418.51 332.30 385.16 381.47 407.76 389.38 375.43 301.13 232.82 175.08 Short Term Provisions 23.56 35.10 55.43 77.41 37.06 46.39 39.71 27.22 33.21 18.61 Total Liabilities 2,195.89 2,322.37 2,385.77 2,055.46 2,043.67 1,898.46 1,837.36 1,569.55 1,299.20 587.40 Net Block 1,045.12 964.92 1,035.36 878.90 814.17 813.47 807.92 709.04 595.35 264.29 Gross Block 1,271.07 1,156.58 1,128.64 915.77 1,663.33 1,599.11 1,526.04 1,329.52 1,167.48 812.71 Accumulated Depreciation 225.95 191.65 93.29 36.87 849.16 785.64 718.12 620.49 572.13 548.42 Non Current Assets 1,220.61 1,091.77 1,103.83 961.04 911.03 906.45 846.28 736.20 604.41 266.01 Capital Work in Progress 89.28 122.31 65.27 76.13 94.17 90.28 38.12 26.92 8.37 1.73 Non Current Investment 85.71 2.51 2.70 2.71 2.69 2.70 0.24 0.24 0.70 0.00 Long Term Loans & Adv. 0.00 1.52 0.00 2.81 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 975.28 1,230.61 1,281.94 1,094.42 1,132.60 991.96 970.90 815.08 647.14 314.68 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 501.91 563.69 540.17 483.97 490.80 431.43 426.66 340.26 247.88 84.47 Sundry Debtors 249.07 356.11 275.43 200.14 326.24 329.58 347.83 308.23 221.61 127.56 Cash & Bank 50.49 95.31 99.03 55.47 30.96 26.67 34.57 23.96 36.34 11.10 Other Current Assets 173.82 30.75 29.59 22.53 284.61 204.28 161.84 142.64 141.32 91.55 Short Term Loans & Adv. 140.96 184.76 337.73 332.31 272.88 185.21 139.50 119.82 141.09 89.45 Net Current Assets 204.92 341.68 491.71 277.03 235.19 191.10 226.47 204.35 183.45 72.25 Total Assets 2,195.89 2,322.38 2,385.77 2,055.46 2,043.67 1,898.45 1,837.36 1,569.55 1,299.21 587.39

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 75.02 82.04 206.55 28.17 -54.21 41.29 -44.86 44.22 105.78 10.58 PBT -20.74 5.13 8.85 173.39 11.34 24.25 38.81 51.38 51.34 32.97 Adjustment 59.57 62.82 69.62 80.21 37.74 50.36 38.63 26.02 33.09 23.71 Changes in Working Capital 42.23 40.35 144.61 -213.96 -103.30 -33.33 -126.70 -39.12 20.70 -28.47 Cash after chg. in Working capital 81.05 108.30 223.09 39.64 -54.21 41.29 -49.27 38.29 105.13 28.21 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -17.63 Tax Paid -6.03 -26.26 -16.54 -11.47 0.00 0.00 4.41 5.93 0.65 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 3.32 56.17 -38.12 29.83 -11.15 -50.04 -148.56 -107.67 -276.74 -81.50 Net Fixed Assets 9.10 -15.53 38.52 -25.51 -6.97 -49.04 -16.56 -128.68 -148.52 -26.78 Net Investments 0.03 64.34 -64.27 142.45 0.00 -2.50 -132.00 -8.38 -83.77 0.09 Others -5.81 7.36 -12.37 -87.11 -4.18 1.50 0.00 29.39 -44.45 -54.81 Cash from Financing Activity -91.42 -123.23 -174.80 -49.62 58.54 9.48 193.01 57.71 181.73 76.15 Net Cash Inflow / Outflow -13.07 14.98 -6.38 8.38 -6.82 0.74 -0.41 -5.74 10.77 5.23 Opening Cash & Equivalents 24.16 9.18 15.55 7.18 13.99 13.26 13.67 19.41 8.63 3.41 Closing Cash & Equivalent 11.09 24.16 9.18 15.56 7.18 13.99 13.26 13.67 19.41 8.63

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 79.56 422.14 21.42 57.96 154.12 140.48 -117.65 90.11 45.17 23.89 PBT -109.47 66.05 85.71 286.48 99.93 77.54 86.86 97.88 77.81 55.26 Adjustment 125.89 134.05 135.90 124.15 101.94 111.32 101.31 80.43 55.16 32.30 Changes in Working Capital 83.08 237.03 -158.14 -315.94 -47.75 -48.38 -305.83 -94.13 -87.81 -63.67 Cash after chg. in Working capital 99.50 437.13 63.48 94.69 154.12 140.48 -117.65 84.18 45.17 23.89 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -19.94 -14.99 -42.06 -36.73 0.00 0.00 0.00 5.93 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -196.01 -88.87 -163.53 -68.49 -190.42 -106.71 -291.11 -169.59 -424.15 -72.39 Net Fixed Assets 9.10 -15.53 38.52 -25.51 -6.97 -49.04 -16.56 -128.68 -148.52 -26.78 Net Investments 0.03 64.34 -64.27 142.45 0.00 -2.50 -132.00 -8.38 -83.77 0.09 Others -205.14 -137.68 -137.78 -185.43 -183.45 -55.17 -142.55 -32.53 -191.86 -45.70 Cash from Financing Activity 72.44 -337.80 185.66 35.05 40.59 -41.67 419.37 67.10 404.22 53.98 Net Cash Inflow / Outflow -44.02 -4.53 43.56 24.51 4.29 -7.90 10.62 -12.38 25.24 5.47 Opening Cash & Equivalents 94.50 99.03 55.47 30.96 26.67 34.57 23.96 36.34 11.10 5.62 Closing Cash & Equivalent 50.49 94.50 99.03 55.47 30.96 26.67 34.57 23.96 36.34 11.10

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 62.22 64.78 64.15 64.53 45.50 46.03 45.84 42.71 35.15 27.03 ROA -1.73% 0.51% 0.75% 9.27% 0.61% 1.51% 2.47% 4.24% 6.70% 7.43% ROE -3.65% 1.16% 1.88% 28.34% 2.19% 5.09% 7.45% 12.50% 21.15% 22.30% ROCE 2.67% 6.22% 6.01% 22.55% 6.95% 8.74% 9.74% 11.41% 14.51% 16.10% Fixed Asset Turnover 0.59 0.53 0.53 1.14 0.66 0.92 0.94 1.08 1.49 1.80 Receivable days 126.38 195.36 274.06 145.95 262.23 174.74 145.26 111.61 92.79 100.90 Inventory Days 360.12 416.73 403.70 177.37 280.37 166.58 131.17 92.40 67.01 75.00 Payable days 51.74 43.93 69.44 41.99 56.35 44.37 46.49 40.12 20.32 20.58 Cash Conversion Cycle 434.76 568.16 608.32 281.33 486.25 296.96 229.95 163.90 139.47 155.32 Total Debt/Equity 0.59 0.65 0.84 1.09 1.62 1.87 1.71 1.29 1.13 1.65 Interest Cover 0.52 1.10 1.17 3.94 1.19 1.36 1.80 2.62 3.13 2.79

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 56.85 70.35 104.60 85.93 64.20 61.00 58.36 52.74 42.03 35.45 ROA -4.83% 2.44% 3.43% 10.44% 4.25% 3.86% 3.90% 5.83% 6.69% 9.36% ROE -20.75% 7.95% 9.76% 35.18% 16.50% 14.90% 14.81% 23.34% 26.70% 31.18% ROCE -2.69% 7.03% 9.04% 21.86% 11.93% 10.91% 11.93% 13.83% 14.29% 17.80% Fixed Asset Turnover 0.87 1.15 1.16 1.13 0.82 0.88 0.95 0.89 0.67 0.76 Receivable days 104.31 87.64 73.20 65.71 88.94 89.58 88.63 87.21 95.35 97.13 Inventory Days 183.67 153.18 157.64 121.69 125.08 113.47 103.61 96.80 90.76 71.87 Payable days 92.05 79.66 70.90 60.76 60.42 57.00 57.11 62.91 65.22 47.96 Cash Conversion Cycle 195.94 161.15 159.93 126.64 153.61 146.05 135.14 121.10 120.89 121.04 Total Debt/Equity 1.18 1.05 0.69 1.45 1.63 1.81 1.66 1.36 1.33 1.70 Interest Cover -0.79 1.94 2.04 5.23 2.17 1.90 2.29 2.94 3.74 3.50

Top Investors:

kitara piin 1102

william f harvey

sameer mahendra sampat

tushar rameshchandra mehta

kitara piin 1101

Annual Reports:

News Update:

Vivimed Labs gets approval from Uzbekistan government for two products
8th Mar 2021, 14:04 PM

The company has received approval for Bilastin tablets
Read More
Vivimed Labs gets approval for 1 product from Uzbekistan Government
22nd Feb 2021, 14:05 PM

Paracetamol is also known as acetaminophen, is a medication used to treat pain and fever
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback